Efficacy of statin pretreatment for the prevention of contrast-induced nephropathy: A meta-analysis of randomised controlled trials

International Journal of Clinical Practice

Volumn 65, Issue 5, 2011, Pages 624-630

  Zhang, L ^a,b   Lu, Y ^b   Wu, B ^b   Zhang, S ^a   Jiang, H ^a   Ge, J ^a   Chen, H ^a  

^a FUDAN UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; CREATININE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SIMVASTATIN;

ADULT; AGED; CONTRAST INDUCED NEPHROPATHY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RENAL REPLACEMENT THERAPY; REVIEW; TREATMENT DURATION; TREATMENT OUTCOME;

ACUTE KIDNEY INJURY; AGED; CONTRAST MEDIA; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; PUBLICATION BIAS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 79954531172     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2010.02588.x     Document Type: Review

References (36)

1. McCullough PA, Adam A, Becker CR, et al., Epidemiology and prognostic implications of contrast-induced nephropathy. Am J Cardiol 2006; 98: 5K-13K.
2. Tepel M, Aspelin P, Lameire N,. Contrast-induced nephropathy: a clinical and evidence-based approach. Circulation 2006; 113: 1799-806. (Pubitemid 43958473)
3. McCullough PA, Wolyn R, Rocher LL, Levin RN, O'Neill WW,. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 1997; 103: 368-75. (Pubitemid 27506242)
4. Rihal CS, Textor SC, Grill DE, et al., Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 2002; 105: 2259-64. (Pubitemid 34535335)
5. Gruberg L, Mintz GS, Mehran R, et al., The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol 2000; 36: 1542-8.
6. Druml W,. Prevention and therapy of acute renal failure: the importance of metabolic intervention. Wien Klin Wochenschr 2007; 119: 201-4. (Pubitemid 46895798)
7. McCullough PA,. Contrast-induced acute kidney injury. J Am Coll Cardiol 2008; 51: 1419-28. (Pubitemid 351471786)
8. Stacul F, Adam A, Becker CR, et al., Strategies to reduce the risk of contrast-induced nephropathy. Am J Cardiol 2006; 98: 59K-77K.
9. Maioli M, Toso A, Leoncini M, et al., Sodium bicarbonate versus saline for the prevention of contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. J Am Coll Cardiol 2008; 52: 599-604.
10. Brar SS, Shen AY, Jorgensen MB, et al., Sodium bicarbonate vs sodium chloride for the prevention of contrast medium-induced nephropathy in patients undergoing coronary angiography: a randomized trial. JAMA 2008; 300: 1038-46.
11. Spargias K, Alexopoulos E, Kyrzopoulos S, et al., Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. Circulation 2004; 110: 2837-42. (Pubitemid 39473606)
12. Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W,. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 2000; 343: 180-4. (Pubitemid 30489215)
13. Goldenberg I, Matetzky S,. Nephropathy induced by contrast media: pathogenesis, risk factors and preventive strategies. Can Med Assoc J 2005; 172: 1461-71. (Pubitemid 40803495)
14. Tumlin J, Stacul F, Adam A, et al., Pathophysiology of contrast-induced nephropathy. Am J Cardiol 2006; 98: 14K-20K.
15. Trochu JN, Mital S, Zhang XP, et al., Preservation of no production by statins in the treatment of heart failure. Cardiovasc Res 2003; 60: 250-8. (Pubitemid 37412358)
16. Mozaffarian D, Minami E, Letterer RA, Lawler RL, McDonald GB, Levy WC,. The effects of atorvastatin (10 mg) on systemic inflammation in heart failure. Am J Cardiol 2005; 96: 1699-704. (Pubitemid 41790394)
17. Pliquett RU, Cornish KG, Zucker IH,. Statin therapy restores sympathovagal balance in experimental heart failure. J Appl Physiol 2003; 95: 700-4. (Pubitemid 36944294)
18. Gueler F, Rong S, Park JK, et al., Postischemic acute renal failure is reduced by short-term statin treatment in a rat model. J Am Soc Nephrol 2002; 13: 11.
19. Park JK, Muller DN, Mervaala EMA, et al., Cerivastatin prevents angiotensin ii-induced renal injury independent of blood pressure- and cholesterol-lowering effects. Kidney Int 2000; 58: 1420-30.
20. Yoshida S, Kamihata H, Nakamura S, et al., Prevention of contrast-induced nephropathy by chronic pravastatin treatment in patients with cardiovascular disease and renal insufficiency. J Cardiol 2009; 54: 192-8.
21. Zhao JL, Yang YJ, Zhang YH, You SJ, Wu YJ, Gao RL,. Effect of statins on contrast-induced nephropathy in patients with acute myocardial infarction treated with primary angioplasty. Int J Cardiol 2008; 126: 435-6.
22. Khanal S, Attallah N, Smith DE, et al., Statin therapy reduces contrast-induced nephropathy: an analysis of contemporary percutaneous interventions. Am J Med 2005; 118: 843-9. (Pubitemid 41097461)
23. Attallah N, Yassine L, Musial J, Yee J, Fisher K,. The potential role of statins in contrast nephropathy. Clin Nephrol 2004; 62: 273-8. (Pubitemid 39386803)
24. Patti G, Nusca A, Chello M, et al., Usefulness of statin pretreatment to prevent contrast-induced nephropathy and to improve long-term outcome in patients undergoing percutaneous coronary intervention. Am J Cardiol 2008; 101: 279-85. (Pubitemid 351162953)
25. Toso A, Maioli M, Leoncini M, et al., Usefulness of atorvastatin (80 mg) in prevention of contrast-induced nephropathy in patients with chronic renal disease. Am J Cardiol 2010; 105: 288-92.
26. Jo SH, Koo BK, Park JS, et al., Prevention of radiocontrast medium-induced nephropathy using short-term high-dose simvastatin in patients with renal insufficiency undergoing coronary angiography (promiss) trial-a randomized controlled study. Am Heart J 2008; 155: e491-8.
27. Jadad AR, Moore RA, Carroll D, et al., Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17: 1-12. (Pubitemid 26120810)
28. Begg CB, Mazumdar M,. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50: 1088-101.
29. Egger M, Davey Smith G, Schneider M, Minder C,. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-34. (Pubitemid 27387172)
30. Jo SH, Koo BK, Youn TJ, et al., Prevention of contrast induced nephropathy by short-term statin in patients with renal insufficiency undergoing coronary angiography: a randomized controlled trial. Am J Cardiol 2005; 96: 115H-6H.
31. Ozhan H, Erden I, Ordu S, et al., Efficacy of short-term high-dose atorvastatin for prevention of contrast-induced nephropathy in patients undergoing coronary angiography. Angiology 2010; 61: 711-4.
32. Kaya C, Pabuccu R, Cengiz SD, Dunder I,. Comparison of the effects of atorvastatin and simvastatin in women with polycystic ovary syndrome: a prospective, randomized study. Exp Clin Endocrinol Diabetes 2010; 118: 161-6.
33. Hurks R, Hoefer IE, Vink A, et al., Different effects of commonly prescribed statins on abdominal aortic aneurysm wall biology. Eur J Vasc Endovasc Surg 2010; 39: 569-76.
34. Parfrey PS, Griffiths SM, Barrett BJ, et al., Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. N Engl J Med 1989; 320: 143-9. (Pubitemid 19033091)
35. Solomon R, Werner C, Mann D, D'Elia J, Silva P,. Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N Engl J Med 1994; 331: 1416-20. (Pubitemid 24348355)
36. Aspelin P, Aubry P, Fransson SG, Strasser R, Willenbrock R, Berg KJ,. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 2003; 348: 491-9. (Pubitemid 36159884)